Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes
NCT00396851 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2006-11-08
Summary
The study plans to compare the glucose-lowering effect of gurmar, a herbal preparation, with metformin in patients with type 2 diabetes
Conditions
Interventions
- DRUG
-
Gurmar
- DRUG
Sponsors & Collaborators
-
Indian Council of Medical Research
collaborator OTHER_GOV -
International Clinical Epidemiology Network (INCLEN) TRUST
collaborator NETWORK -
Post Graduate Institute of Medical Education and Research, Chandigarh
lead OTHER
Principal Investigators
-
Deepak Bhasin, MD,DM · Post Graduate Institute of Medical Education and Research, Chandigarh
-
Anil Bhansali · Post Graduate Institute of Medical Education and Research, Chandigarh
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
Countries
- India
Study Locations
More Related Trials
-
Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics
NCT00698230 ·Status: COMPLETED ·Phase: PHASE2
-
Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
NCT01999218 ·Status: COMPLETED ·Phase: PHASE3
-
Fenofibrate Versus Curcumin in Type 2 Diabetic Patients
NCT04528212 ·Status: COMPLETED ·Phase: PHASE4
-
Chiglitazar Added to Metformin for Type 2 Diabetes
NCT04807348 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).
NCT02033889 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes
NCT02089126 ·Status: UNKNOWN ·Phase: PHASE3
-
Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease
NCT06932874 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes
NCT00698789 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin
NCT01929863 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus
NCT05281029 ·Status: UNKNOWN
-
Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled
NCT01699932 ·Status: COMPLETED ·Phase: PHASE3
-
COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.
NCT02395237 ·Status: WITHDRAWN ·Phase: PHASE1
-
Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil
NCT00566865 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes
NCT00614120 ·Status: COMPLETED ·Phase: PHASE3
-
BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in Comparison to Each Component Administered Alone
NCT03355014 ·Status: COMPLETED ·Phase: PHASE1
-
Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone
NCT00095030 ·Status: COMPLETED ·Phase: PHASE3
-
Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride
NCT00633425 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DM
NCT00612144 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus
NCT01037842 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM)
NCT00908921 ·Status: COMPLETED ·Phase: PHASE4
-
Initial Combination of Gemigliptin and Metformin on Microbiota Change
NCT02609815 ·Status: COMPLETED ·Phase: NA
-
Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes
NCT01386671 ·Status: COMPLETED ·Phase: PHASE3
-
Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin
NCT03907423 ·Status: COMPLETED ·Phase: NA
-
A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes
NCT00035568 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers
NCT03851341 ·Status: COMPLETED ·Phase: PHASE1